| (S)-nicotine | multiple interactions | ISO | RGD:1557698 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of ITM2B mRNA; more ... | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:1557698 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of ITM2B mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:1557698 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of ITM2B mRNA; more ... | CTD | PMID:20230807 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1557698 | 6480464 | Ethinyl Estradiol affects the expression of ITM2B mRNA | CTD | PMID:17555576 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of ITM2B mRNA | CTD | PMID:17108234 PMID:19400957 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of ITM2B mRNA | CTD | PMID:19400957 PMID:17108234 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1557698 | 6480464 | Ethinyl Estradiol results in decreased expression of ITM2B mRNA | CTD | PMID:19400957 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1557698 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ITM2B mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1557698 | 6480464 | Ethinyl Estradiol results in increased expression of ITM2B mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ITM2B mRNA | CTD | PMID:18796159 PMID:18465118 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ITM2B mRNA | CTD | PMID:18465118 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1557698 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ITM2B mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ITM2B mRNA | CTD | PMID:18465118 PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1557698 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ITM2B mRNA | CTD | PMID:17942748 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1557698 | 6480464 | Tretinoin results in decreased expression of ITM2B mRNA | CTD | PMID:16788091 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of ITM2B mRNA | CTD | PMID:20488242 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1353059 | 6480464 | Tretinoin results in increased expression of ITM2B mRNA | CTD | PMID:16140955 PMID:16054129 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1353059 | 6480464 | Tretinoin results in increased expression of ITM2B mRNA | CTD | PMID:16054129 PMID:16140955 |
| benzo[a]pyrene | increases expression | ISO | RGD:1557698 | 6480464 | Benzo(a)pyrene results in increased expression of ITM2B mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:1353059 | 6480464 | Benzo(a)pyrene results in increased expression of ITM2B mRNA | CTD | PMID:22316170 |
| caffeine | multiple interactions | ISO | RGD:1557698 | 6480464 | [Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of ITM2B mRNA; more ... | CTD | PMID:20230807 |
| cisplatin | increases expression | ISO | RGD:1557698 | 6480464 | Cisplatin results in increased expression of ITM2B mRNA | CTD | PMID:21151649 |
| cobalt dichloride | increases expression | ISO | RGD:1353059 | 6480464 | cobaltous chloride results in increased expression of ITM2B mRNA | CTD | PMID:19376846 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1353059 | 6480464 | Copper Sulfate results in decreased expression of ITM2B mRNA | CTD | PMID:19549813 |
| diarsenic trioxide | increases expression | ISO | RGD:1353059 | 6480464 | arsenic trioxide results in increased expression of ITM2B mRNA | CTD | PMID:20458559 |
| hydrogen peroxide | multiple interactions | ISO | RGD:1353059 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ITM2B protein | CTD | PMID:18951874 |
| paclitaxel | affects response to substance | ISO | RGD:1353059 | 6480464 | ITM2B protein affects the susceptibility to Paclitaxel | CTD | PMID:16217747 |
| paracetamol | affects expression | ISO | RGD:1557698 | 6480464 | Acetaminophen affects the expression of ITM2B mRNA | CTD | PMID:17562736 |
| pyrogallol | increases expression | ISO | RGD:1557698 | 6480464 | Pyrogallol results in increased expression of ITM2B mRNA | CTD | PMID:20362636 |
| tamoxifen | affects expression | ISO | RGD:1353059 | 6480464 | Tamoxifen affects the expression of ITM2B mRNA | CTD | PMID:14699072 |
| tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of ITM2B mRNA | CTD | PMID:19400957 |
| tamoxifen | affects expression | ISO | RGD:1557698 | 6480464 | Tamoxifen affects the expression of ITM2B mRNA | CTD | PMID:17555576 |
| tamoxifen | decreases expression | ISO | RGD:1557698 | 6480464 | Tamoxifen results in decreased expression of ITM2B mRNA | CTD | PMID:19400957 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1353059 | 6480464 | tert-Butylhydroperoxide results in decreased expression of ITM2B mRNA | CTD | PMID:15336504 |
| theophylline | multiple interactions | ISO | RGD:1353059 | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ITM2B protein | CTD | PMID:18951874 |